Groowe Groowe / Newsroom / PLX
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

PLX News

Protalix BioTherapeutics, Inc. Common Stock

Chronic Obstructive Pulmonary Disease Clinical Trial Landscape Expands: Over 65 Companies Advancing Next-Generation Therapies | DelveInsight

globenewswire.com
REGN SNY AZN AVTX BHVN GSK RPRX PLUR MESO EDIT CRSP NTLA ALNY MRNA PFE NVS TEVA LPCN GILD AMGN BMY ABBV LLY JNJ BIIB XRAY HOLX SYK ISRG COO MASI CYTK ATRC RDNT GH EXAS CLDX ACRS ADPT ALKS APLS ASMB CHKP CODX CRBU CTAS DAKT DBI DDS DELL DLTR DOCU DOX DXCM EA EBAY ELAN EPAM ERIC ETSY EXPD F FAST FCX FIS FISV FMC FOX FRPT FTNT G GLPG GM GNRC GOOG GOOGL GRMN GWW HCA HD HII HLT HON HPQ HRB HRL HSIC HST HTZ HWM IBM ICE ICLR IDXX ILMN INCY INGN INTC INTU IPGP IQV IRTC ITW IVZ JBL JCI JEF JPM KDP KHC KIM KMB KMI KMX KO KODK L LBTYA LBRDK LIN LKQ LNT LOPE LOW LRCX LULU LUV LYFT M MA MAR MAS MAT MDLZ MELI MGM MCHP MICC MITK MKC MLCO MNST MO MRVL MS MSFT MSI MTCH MTN MU NCLH NDAQ NDSN NEE NEM NFLX NI NKE NOC NOV NOW NRG NTAP NTES NTRS NUE NVDA NWSA NXPI O ODFL OFG OGN OKE OMC OMER ON ORCL ORLY OSBC OTIS OVV P PANW PAYX PCAR PCG PDD PEP PERI PETS PFG PGR PG PH PHG PHI PHM PI PII PKX PLD PLUG PLX PM PNC PPC PPG PPL PRGO PRGS PRU PSA PSMT PTC PTEN PTON PYPL QCOM QGEN QLYS QRVO R RBLX RCL REI RELX RF RGEN RHI RIVN RL RLX RMD RNG ROKU ROST RRC RRGB RS RSG RTX RUN RVSN S SABR SAN SAVA SBAC SBUX SCHW SD SEE SEIC SEM SIRI SITE SJM SLB SLGN SLP SM SMCI SMLR SNA SNDR SNOW SNPS SO SONY SPG SPGI SPOT SQM SSNC ST STAG STLD STNG STOK STX SUN SWKS SXI SYPR T TAL TCOM TD TDG TDOC TECK TEF TEN TER TFX TGT TGTX THC THO TIGR TJX TLRY TMO TM TNDM TNET TOL TOPS TPH TPL TR TRC TRIP TRMB TRN TROX TRP TRT TS TSLA TSM TSN TT TTC TTEC TTWO TU TV TW TWLO TX TXN TXRH TXT TYL U UAL UDR UEC UHS UL ULTA UMC UMH UNH UNIT UNM UPS URBN USFD USNA USPH UTHR V VRSN VRTX VRSK VTR VTRS W WAB WDC WEC WELL WEN WFC WGO WHR WMB WMS WMT WOOF WPC WPP WSC WSM WST WTI WTW WU WVE WY WYNN XCUR XENE XOM XPEV XPO XRX XTLB XXII XYL YETI YMM YUM Z ZBH ZBRA ZION ZNTL ZUMZ ZYME

Pluxee delivers strong margin expansion and cash generation in H1 Fiscal 2026, reaffirming all full‑year objectives

globenewswire.com
PLX

Form 8-K

sec.gov
PLX

Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results

prnewswire.com
PLX

Organoid COMMONS Announces Formation of Governing Board, Appointment of Alliance Director, and Announces Open Call for New COMMONS Members

globenewswire.com
PLX DBI

Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026

prnewswire.com
PLX

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) ▼

globenewswire.com
PLX

Form 8-K

sec.gov
PLX

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa)

globenewswire.com
PLX

Ellomay Capital Announces Changes in its Principal Shareholders and Board Composition

globenewswire.com
PLX ELLO